NCT00254696View on ClinicalTrials.gov

Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)

PHASE4CompletedINTERVENTIONAL
Enrollment

710

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Bacterial Infection
Interventions
DRUG

Extended-Spectrum-Lactamases (ESBLs)

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00254696 - Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs) | Biotech Hunter | Biotech Hunter